Latest Trump Executive Order Redirects Drug Pricing Debate
Briefly

On May 11, President Trump announced an Executive Order to drastically reduce prescription drug prices in the U.S. by implementing a 'most favored nations' policy, ensuring Americans pay the same price as the lowest paying countries. By blaming the pharmaceutical industry for high prices and asserting that the proposed changes could lead to a price reduction of 30% to 80%, Trump aims to alleviate the financial burden on U.S. citizens while also potentially saving the country trillions of dollars. This approach has faced skepticism in the past, having been blocked previously and debated in Congress.
'Starting today the United States will no longer subsidize the healthcare of foreign countries.... We will no longer tolerate price gouging from big pharma.'
Trump's order aims to reduce drug prices 'almost immediately, by 30% to 80%' via a 'most favored nations' policy.
Read at IPWatchdog.com | Patents & Intellectual Property Law
[
|
]